Chemotherapy

A miniature, three-dimensional heart model, called the “heart-on-a-chip,” successfully used reprogrammed stem cells to determine cardiotoxicity of cancer drugs on the human heart, according to a study published in Lab on a Chip.

A woman in her late 50s is currently receiving treatment for her second bout of breast cancer. She is thought to be in remission, but Neelam Desai, MD, worries about more than just the disease.

Two blood-based biomarkers may help identify patients with cancer who are more likely to experience gastrointestinal symptoms during chemotherapy.

Most oncologists treating non-small cell lung cancer reported more research into immunotherapy treatments, patients with comorbidities and biomarker testing will be vital to improving care, according to results of a nationwide survey.

Cancer survivors with elevated levels of the protein N-terminal pro-brain natriuretic peptide had increased risk for death compared with adults without cancer, according to a study in Journal of the National Cancer Institute.

The FDA approved osimertinib plus platinum-based chemotherapy for certain adults with locally advanced or metastatic non-small cell lung cancer.

A COVID-19 diagnosis led to a delay in receiving chemotherapy among younger patients with acute lymphoblastic leukemia or lymphoblastic lymphoma, results from a retrospective analysis published in JAMA Network Open showed.

Researchers used an artificial intelligence and precision medicine approach that identifies biomarkers that appear superior to standard tests for predicting pancreatic cancer survival, findings in Nature Cancer showed.

Fruquintinib plus paclitaxel significantly improved PFS in patients with advanced gastric or gastroesophageal junction adenocarcinoma, according to results from a phase 3 trial presented during an ASCO Plenary Series session.

In this video, Jason Westin, MD, discusses the results of the Smart Stop trial, presented at ASH Annual Meeting and Exposition.